Viewing Study NCT01141894


Ignite Creation Date: 2025-12-25 @ 1:35 AM
Ignite Modification Date: 2025-12-25 @ 11:49 PM
Study NCT ID: NCT01141894
Status: TERMINATED
Last Update Posted: 2020-09-18
First Post: 2010-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture
Sponsor: Karolinska Institutet
Organization:

Study Overview

Official Title: Evaluation of Costs and Consequences of Alternative Strategies of Intraoperative Fluid and Pharmacological Optimization. A Randomized Clinical Trial
Status: TERMINATED
Status Verified Date: 2020-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: slow recruitment
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GDHT
Brief Summary: The investigators aimed to compare the costs and consequences of 'routine perioperative fluid therapy' and 'GDHT in terms of morbidity, mortality, length of hospital stay, activity of daily living, health related quality of life, cognitive functions and need of social services and up till 12 months following operations of proximal femoral fracture at elderly. The primary hypothesis is that 'GDHT is a better strategy than 'routine fluid therapy' in terms of reduced frequency of postoperative complications.
Detailed Description: The investigation is an open, randomized clinical study of individuals suffering from a proximal femoral fracture. The total study duration for each subject is approximately 12 months (+- 1 month); each patient will have 4'visits' (i.e. when PI extracts data to database) including regular praxis total: at registration; at discharge; 4 months and finally at 12 months after the surgery. For practical and logistic reasons, an interim-analysis will be conducted after approximately 100 patients whose data are completed.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
ID: 2008-1240-31 OTHER Ethical Board of Karolinska Institute Stockholm View